Recent studies have shown that miR-641 expression is reduced in lung cancer tissues, and miR-641 overexpression significantly inhibits the cell survival by targeting MDM2 in lung cancer cells [30,31]. The gene discussed is MDM2; the disease is lung carcinoma.